This most recent twist in the Lykos Therapeutics saga threatens A serious overhaul of the business’s method and path, with Musk ally and billionaire Trader Antonio Gracias showing up to desire to get the company back again towards its nonprofit drug growth roots and a far more Doblinite philosophy.“I spent the weekend chatting lots about that w